Lv4
420 积分 2021-12-13 加入
Mitochondrial Damage Causes Inflammation via cGAS-STING Signaling in Acute Kidney Injury
5个月前
已完结
Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
5个月前
已完结
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
7个月前
已完结
LBA96 Roxadustat for chemotherapy-induced anemia in patients with non-myeloid malignancies: A randomized, open-label, active-controlled, phase III study
7个月前
已关闭
A randomized, double-blind trial of nivolumab (NIVO) vs placebo (PBO) with neoadjuvant chemotherapy (NACT) followed by adjuvant endocrine therapy (ET) ± NIVO in patients (pts) with high-risk, ER+ HER2− primary breast cancer (BC)
7个月前
已完结
LBA21 KEYNOTE-756: Phase III study of neoadjuvant pembrolizumab (pembro) or placebo (pbo) + chemotherapy (chemo), followed by adjuvant pembro or pbo + endocrine therapy (ET) for early-stage high-risk ER+/HER2– breast cancer
7个月前
已关闭
PD‐L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistance
8个月前
已完结
Switching anti-EGFR antibody re-sensitizes head and neck cancer patient following acquired resistance to cetuximab
8个月前
已完结
Switching anti-EGFR antibody re-sensitizes head and neck cancer patient following acquired resistance to cetuximab
8个月前
已完结
A valuable glioblastoma prognostic marker driven by radiosensitivity
9个月前
已关闭
皖公网安备34019202002308
